Literature DB >> 21236260

The proteome of the insoluble Schistosoma mansoni eggshell skeleton.

Saskia Dewalick1, Michiel L Bexkens, Bas W M van Balkom, Ya-Ping Wu, Cornelis H Smit, Cornelis H Hokke, Philip G de Groot, Albert J R Heck, Aloysius G M Tielens, Jaap J van Hellemond.   

Abstract

In schistosomiasis, the majority of symptoms of the disease is caused by the eggs that are trapped in the liver. These eggs elicit an immune reaction that leads to the formation of granulomas. The eggshell, which is a rigid insoluble structure built from cross-linked proteins, is the site of direct interaction between the egg and the immune system. However, the exact protein composition of the insoluble eggshell was previously unknown. To identify the proteins of the eggshell of Schistosoma mansoni we performed LC-MS/MS analysis, immunostaining and amino acid analysis on eggshell fragments. For this, eggshell protein skeleton was prepared by thoroughly cleaning eggshells in a four-step stripping procedure of increasing strength including urea and SDS to remove all material that is not covalently linked to the eggshell itself, but is part of the inside of the egg, such as Reynold's layer, von Lichtenberg's envelope and the miracidium. We identified 45 proteins of which the majority are non-structural proteins and non-specific for eggs, but are house-keeping proteins that are present in large quantities in worms and miracidia. Some of these proteins are known to be immunogenic, such as HSP70, GST and enolase. In addition, a number of schistosome-specific proteins with unknown function and no homology to any known annotated protein were found to be incorporated in the eggshell. Schistosome-specific glycoconjugates were also shown to be present on the eggshell protein skeleton. This study also confirmed that the putative eggshell protein p14 contributes largely to the eggshell. Together, these results give new insights into eggshell composition as well as eggshell formation. Those proteins that are present at the site and time of eggshell formation are incorporated in the cross-linked eggshell and this cross-linking does no longer occur when the miracidium starts secreting proteins.
Copyright © 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236260     DOI: 10.1016/j.ijpara.2010.12.005

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  18 in total

1.  Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis.

Authors:  Nawal M Boukli; Bonnibel Delgado; Martha Ricaurte; Ana M Espino
Journal:  J Parasitol       Date:  2011-03-11       Impact factor: 1.276

2.  Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs.

Authors:  Cornelis H Smit; Angela van Diepen; D Linh Nguyen; Manfred Wuhrer; Karl F Hoffmann; André M Deelder; Cornelis H Hokke
Journal:  Mol Cell Proteomics       Date:  2015-04-16       Impact factor: 5.911

3.  Immunolocalization of the 29 kDa Schistosoma haematobium species-specific antigen: a potential diagnostic marker for urinary schistosomiasis.

Authors:  Uri S Markakpo; George E Armah; Julius N Fobil; Richard H Asmah; Isaac Anim-Baidoo; Alfred K Dodoo; Parnor Madjitey; Edward E Essuman; Somei Kojima; Kwabena M Bosompem
Journal:  BMC Infect Dis       Date:  2015-04-26       Impact factor: 3.090

4.  Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects.

Authors:  Christin Buro; Svenja Beckmann; Katia C Oliveira; Colette Dissous; Katia Cailliau; Richard J Marhöfer; Paul M Selzer; Sergio Verjovski-Almeida; Christoph G Grevelding
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

5.  H-IPSE Is a Pathogen-Secreted Host Nucleus-Infiltrating Protein (Infiltrin) Expressed Exclusively by the Schistosoma haematobium Egg Stage.

Authors:  Luke F Pennington; Abdulaziz Alouffi; Evaristus C Mbanefo; Debalina Ray; David M Heery; Theodore S Jardetzky; Michael H Hsieh; Franco H Falcone
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

6.  Quantitative label-free proteomic analysis of human urine to identify novel candidate protein biomarkers for schistosomiasis.

Authors:  Olugbenga Samson Onile; Bridget Calder; Nelson C Soares; Chiaka I Anumudu; Jonathan M Blackburn
Journal:  PLoS Negl Trop Dis       Date:  2017-11-08

Review 7.  Mucin-Type O-Glycosylation in Invertebrates.

Authors:  Erika Staudacher
Journal:  Molecules       Date:  2015-06-09       Impact factor: 4.411

8.  Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.

Authors:  Alison M Elliott; Meta Roestenberg; Anne Wajja; Christopher Opio; Francis Angumya; Moses Adriko; Moses Egesa; Serah Gitome; Joseph Mfutso-Bengo; Philip Bejon; Melissa Kapulu; Zoe Seager; Tom Lutalo; Winfred Badanga Nazziwa; Asuman Muwumuza; Maria Yazdanbakhsh; Pontiano Kaleebu; Narcis Kabatereine; Edridah Tukahebwa
Journal:  AAS Open Res       Date:  2018-08-06

9.  The iron distribution and magnetic properties of schistosome eggshells: implications for improved diagnostics.

Authors:  Stephan Karl; Lucía Gutiérrez; Rafael Lucyk-Maurer; Roland Kerr; Renata R F Candido; Shu Q Toh; Martin Saunders; Jeremy A Shaw; Alexandra Suvorova; Andreas Hofmann; Michael J House; Robert C Woodward; Carlos Graeff-Teixera; Timothy G St Pierre; Malcolm K Jones
Journal:  PLoS Negl Trop Dis       Date:  2013-05-16

10.  Transcriptome analyses of inhibitor-treated schistosome females provide evidence for cooperating Src-kinase and TGFβ receptor pathways controlling mitosis and eggshell formation.

Authors:  Christin Buro; Katia C Oliveira; Zhigang Lu; Silke Leutner; Svenja Beckmann; Colette Dissous; Katia Cailliau; Sergio Verjovski-Almeida; Christoph G Grevelding
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.